Osteopontin ablation ameliorates muscular dystrophy by shifting macrophages to a pro-regenerative phenotype

J Cell Biol. 2016 Apr 25;213(2):275-88. doi: 10.1083/jcb.201510086. Epub 2016 Apr 18.

Abstract

In the degenerative disease Duchenne muscular dystrophy, inflammatory cells enter muscles in response to repetitive muscle damage. Immune factors are required for muscle regeneration, but chronic inflammation creates a profibrotic milieu that exacerbates disease progression. Osteopontin (OPN) is an immunomodulator highly expressed in dystrophic muscles. Ablation of OPN correlates with reduced fibrosis and improved muscle strength as well as reduced natural killer T (NKT) cell counts. Here, we demonstrate that the improved dystrophic phenotype observed with OPN ablation does not result from reductions in NKT cells. OPN ablation skews macrophage polarization toward a pro-regenerative phenotype by reducing M1 and M2a and increasing M2c subsets. These changes are associated with increased expression of pro-regenerative factors insulin-like growth factor 1, leukemia inhibitory factor, and urokinase-type plasminogen activator. Furthermore, altered macrophage polarization correlated with increases in muscle weight and muscle fiber diameter, resulting in long-term improvements in muscle strength and function in mdx mice. These findings suggest that OPN ablation promotes muscle repair via macrophage secretion of pro-myogenic growth factors.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Cell Polarity
  • Macrophages / cytology
  • Macrophages / metabolism*
  • Macrophages / physiology
  • Mice
  • Mice, Inbred C57BL
  • Mice, Knockout
  • Muscles / metabolism
  • Muscles / pathology
  • Muscles / physiology
  • Muscular Dystrophy, Animal / pathology*
  • Natural Killer T-Cells / metabolism
  • Natural Killer T-Cells / physiology
  • Osteopontin / genetics
  • Osteopontin / metabolism
  • Osteopontin / physiology*
  • Phenotype
  • Regeneration

Substances

  • Osteopontin